Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 21, 4 Issues, 2021
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

Open Access Articles

Efficacy of Cangrelor as Bridging Therapy Post PCI

, 2020; 20(3): 227 - 231

Abdul A. Khan, Ghulam Murtaza*, Muhammad Khalid, Mathew Finniss and Thomas Helton










Prognostic Value of Cardiac Biomarkers Assessment in Combination with Myocardial 2D Strain Echocardiography for Early Detection of Anthracycline-Related Cardiac Toxicity

, 2020; 20(1): 74 - 83

Mohammad P. Mahjoob, Seyed A. Sheikholeslami, Morvarid Dadras, Hamdollah Mansouri, Mahshid Haghi, Mohammadreza Naderian, Leila Sadeghi, Mohammadreza Tabary* and Isa Khaheshi*





Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized Trials

, 2020; 20(1): 3 - 15

Sukhdeep Bhogal, Debabrata Mukherjee, Jayant Bagai, Huu T. Truong, Hemang B. Panchal, Ghulam Murtaza, Mustafa Zaman, Rajesh Sachdeva and Timir K. Paul*












Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
(Canada)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog